Cytological study of palpable breast lumps (407 cases) with their histological correlation

Chokshi, Mital Hemendrakumar; Mehta, Nandita

doi:10.5455/ijmsph.2013.191120134

Cited by 7 publications

(9 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The findings of this study, as with many other studies in developing countries, supports the notion that most breast lesions can accurately be diagnosed by FNAC, a technique that is ideal for use in resource‐limited health settings . This is due to simplicity of the technique, its minimum invasiveness, cost‐effectiveness, high accuracy, and the efficiency of result reporting . The cost of FNAC in our setting is <20 cents (US) compared to $20(US) for any histopathology specimen.…”

Section: Discussionsupporting

confidence: 85%

“…FNAC is commonly used as part of the triple diagnostic assessment, which includes clinical breast examination and radiology (mammography and/or ultrasonography) in addition to FNAC . The specificity, sensitivity, and diagnostic accuracy is above 95%, and is almost 100% for both benign and malignant lesions when all three modalities are applied . In Sudan, FNAC has proven to be a simple, accurate, and cost‐effective method of diagnosis for most breast lesions, with a 92.6% sensitivity, 95.2% specificity, 95.5% positive predictive value, and 92.2% negative predictive value .…”

mentioning

confidence: 99%

See 1 more Smart Citation

Cytomorphology of palpable breast lesions: Diagnostic utility of FNAC in a developing country

Elmadhoun

Almobarak

Ibrahim

et al. 2015

Diagnostic Cytopathology

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 85%

mentioning

confidence: 99%

Cytomorphology of palpable breast lesions: Diagnostic utility of FNAC in a developing country

Elmadhoun

Almobarak

Ibrahim

et al. 2015

Diagnostic Cytopathology

View full text Add to dashboard Cite

show abstract

“…13,14,15 In the present study, incidence of benign lesions which accounts for 268/434 cases (61.7%) predominated over inflammatory lesions (23.1%) and malignant lesions ( In the current study, the most common cytologically diagnosed inflammatory/infectious lesion was acute/subacute mastitis (11.5%) and benign lesion was fibroadenoma (32.7%) which correlates with the finding of other studies. [16][17][18] The commonest malignant lesion found in our study was ductal carcinoma and our finding was in agreement with most of the available literatures.…”

Section: Discussionsupporting

confidence: 92%

Cytological Spectrum of Female Breast Lesions in a Tertiary Centre: A Two Years Study

Das¹,

Khuraijam²,

Khuraijam³

et al. 2019

jebmh

View full text Add to dashboard Cite

BACKGROUNDPalpable breast lumps are a common occurrence in women all over the world. The prevalence of non-neoplastic and neoplastic lesions varies from region to region. Fine Needle Aspiration Cytology (FNAC) is a rapid, minimally invasive, reliable and relatively simple diagnostic method. We wanted to study the frequencies of different lesions in FNAC of breast lump in our region and to observe cyto-histological correlation wherever possible. METHODSA two years prospective study was carried out in the department of pathology, RIMS, Imphal during the period January 2016 -December 2017. A total of 434 cases of breast lesions were encountered during this period. RESULTSOf the total 434 cases infectious/inflammatory lesions were 100 (23.1%), benign 268 (61.7%), malignant 40 (9.2%), suspicious for malignancy 02 (0.5%), unsatisfactory 18 (4.1%), and others 6 (1.4%). The most frequent infectious/inflammatory lesion was acute mastitis in 50 (11.5%) followed by sub-areolar abscess in 17 (3.9%) and fat necrosis in 17 (3.9%). Fibroadenoma in 142 (32.7%) cases was the most common benign breast lesion followed by benign proliferative breast lesion without atypia 14 (22.1%). Among the malignant, 39 (9%) cases were carcinoma and one case (0.2%) was lymphoma. Mean age of presentation was 32.82 years. Most commonly involved age group was 21-30 years and right breast was more commonly involved. Cytohistological correlation was done in 41 cases and 35 benign and 6 malignant cases diagnosed cytologically were confirmed by histology, though there were cases with variable diagnosis. So, in differenting benign from malignant lesions, the sensitivity, specificity, positive predictive value, negative predictive value was 100%. CONCLUSIONSFNAC is a reliable and rapid diagnostic tool in the workup of breast lesions. It also helps in differentiating between benign and malignant breast lesions and plays an important role in management of the patient. KEYWORDSFNAC, Breast lump, Neoplastic HOW TO CITE THIS ARTICLE: Das KK, Khuraijam SD, Khuraijam S, et al. Cytological spectrum of female breast lesions in a tertiary centre: a two years study.

show abstract

“…A study conducted by Khan et al [5] showed similar results with most affected age group being 41-50 years [Tables 12 and 13]. Khan et al [5] 74 24 (32.4) 03 (4.1) 41 (55.4) 06 (8.1) 0 (0) Yusuf et al [8] 200 109 (54.5) 20 (10) 44 (22) 27 (13.5) 0 (0) Panjvani et al [9] 222 150 (68.18) 01 (0.45) 69 (31.08) 02 (0.90) 00 (00) Chokshi et al [10] 407 categorized as granulomatous pathology, three cases were found to have ZN positivity and were thus reported as tuberculous mastitis. Of the two cases that were labeled as granulomatous mastitis, one patient had excision of mass and HPE confirmed a nontuberculous granulomatous mastitis.…”

Section: Discussionmentioning

confidence: 67%

“…The high number of FNR recorded by this study may be predominantly due to sampling error and/or inadequate sampling. [13] Khan et al [5] 74 24 (32.4) 23 (95.83) 01 (4.17) Yusuf et al [8] 200 109 (54.5) 99 (90.82) 10 (9.17) Panjvani et al [9] 91 46 (50.55) 45 (97.83) 01 (2.17) Chokshi et al [10] 161 Yusuf et al [8] 200 1.2 12 Panjvani et al [9] 91 00 2.17 Nggada et al [15] 220 1.9 2.9 Present study 30 6.67 13.33…”

Section: Fibroepithelial Lesions (30 Cases)mentioning

confidence: 99%

Cytomorphological patterns of breast lesions diagnosed on fine-needle aspiration cytology in a tertiary care hospital

Singh¹,

Chaudhry²,

Nauhria³

et al. 2015

Int J Med Sci Public Health

View full text Add to dashboard Cite

carcinoma of breast, which is the leading cause of morbidity and mortality. [1] In India, breast carcinoma is the second most common malignant neoplasm (next to cervical cancer) in females, comprising 22.2% of all new cancer diagnoses and 17.2% of all cancer deaths. [2] The management of breast disease needs a deliberate, synchronized diagnostic and treatment strategy. Fine-needle aspiration cytology (FNAC) is an important diagnostic tool for the preoperative diagnosis of palpable and non-palpable breast lesions. The procedure has advantages in that it provides rapid and accurate diagnosis and serves a cost-effective tool for the treatment of breast masses. [3] It differentiates cysts from a solid tumor and can be used as a therapeutic procedure when a cyst is encountered. Whenever a malignancy is diagnosed, Background: Fine-needle aspiration cytology (FNAC) has been established as a highly accurate diagnostic technique over the past few decades. It is a rapid, reliable, and safe initial diagnostic tool used for both non-neoplastic and neoplastic breast lesions. Objectives: To study the cytomorphological patterns of various breast lesions diagnosed on Fine Needle Aspiration cytology. Materials and Methods: This study was carried out on 100 patients who presented with palpable lumps in breast in the

show abstract

Cytological study of palpable breast lumps (407 cases) with their histological correlation

Cited by 7 publications

References 11 publications

Cytomorphology of palpable breast lesions: Diagnostic utility of FNAC in a developing country

Cytomorphology of palpable breast lesions: Diagnostic utility of FNAC in a developing country

Cytological Spectrum of Female Breast Lesions in a Tertiary Centre: A Two Years Study

Cytomorphological patterns of breast lesions diagnosed on fine-needle aspiration cytology in a tertiary care hospital

Contact Info

Product

Resources

About